The dedication of Teva Neuroscience to helping people take a total approach to managing
multiple sclerosis has guided business decisions since the founding of the company.
The company will continue to introduce new programs and services and expand existing
programs to help patients, families, caregivers, and health professionals deal with
a difficult disease.
For information on Multiple Sclerosis, please click here.
For information on COPAXONE®, please
click here.
In addition, we are confident that this total approach could be applied to other
neurological disorders that are, like MS, complicated, devastating diseases. We
will maintain our
commitment to MS, but we are exploring opportunities to expand that commitment to
providing therapy and hope to people living with other neurological illnesses.
For information on Parkinson's Disease, please click
here.
For information on AZILECT®, please click here
If you would like more information about products currently in development by Teva
Pharmaceuticals, please click here.